Worth reading
53Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
27000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of new shares through the partial exercise of Series 21 Stock Acquisition Rights
Who receives how much27,000,000Shares
27,000,000 shares of common stock
ORCHID PLUS PTE.LTD. (270,000 units, 27,000,000 shares of common stock)
The lower thin line represents the existing number of shares to which these shares will be added.
¥29 per share
Total issue value
¥783,000,000
Amount of funds to be raised
Total payment amount: ¥783,000,000; approximate net proceeds: Not disclosed
Existing Shares and Increase
—Rate of increase
323,356,980 shares350,356,980Shares
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥29 per share; adjustment provision and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 565,720 units; remaining after exercise: 115,720 units
Payment date
15 June 2026
Most recent equity financing
Offering of Series 21 Stock Acquisition Rights to be issued through a third-party allotment, dated 9 August 2024
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares through the partial exercise of Series 21 Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 27,000,000 shares of common stock |
| Issue price and disposal price | ¥29 per share |
| Total issue value | ¥783,000,000 |
| Amount of funds to be raised | Total payment amount: ¥783,000,000; approximate net proceeds: Not disclosed |
| Payment date | 15 June 2026 |
| Intended allottee | ORCHID PLUS PTE.LTD. (270,000 units, 27,000,000 shares of common stock) |
| Total number of issued shares | 323,356,980 shares → 350,356,980 shares |
| Exercise price | ¥29 per share; adjustment provision and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 565,720 units; remaining after exercise: 115,720 units |
| Most recent equity financing | Offering of Series 21 Stock Acquisition Rights to be issued through a third-party allotment, dated 9 August 2024 |
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Stated capital increased as a result of the partial exercise of the Series 21 Stock Acquisition Rights by ORCHID PLUS PTE.LTD., the allottee.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.